Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (13,985)	$ (1,397)
Adjustments to reconcile net loss to net cash provided by operating activities:
Dividends on Series B preferred stock classified as interest expense	7,300
(Gain) loss on the disposal of assets	(1,204)	(25)
Impairment charges	(103)	889
Stock-based compensation	1	41
Depreciation and amortization	3,806	3,911
Net barter (income) loss	(125)	(182)
Provision for trade doubtful accounts	261	585
Amortization of deferred financing costs	2,514	2,501
Amortization of original issued discount	1,120	982
Deferred income taxes	872	428
Unearned revenue-barter	151	370
Changes in operating assets and liabilities:
Trade receivables	2,688	(3,744)
Prepaid expenses and other current assets	(658)	(1,489)
Other assets	449	(537)
Accounts payable and accrued expenses	(708)	3,295
Accrued interest	8,527	8,485
Other liabilities	(185)	(197)
Net cash provided by operating activities	10,721	13,916
Cash flows from investing activities:
Purchases of property and equipment	(1,868)	(1,469)
Proceeds from the sale of property and equipment	1,270	36
Net cash used in investing activities	(598)	(1,433)
Cash flows from financing activities:
Payment of Series B preferred stock and/or related cash dividends		(2,483)
Payments of other long-term debt	(2,919)	(2,923)
Net cash used in financing activities	(2,919)	(5,406)
Net increase in cash and cash equivalents	7,204	7,077
Cash and cash equivalents at beginning of period	23,566	26,660
Cash and cash equivalents at end of period	30,770	33,737
Supplemental cash flows information:
Interest paid	17,615	17,795
Income tax paid	358
Noncash investing and financing activities:
Unrealized gain on derivative instrument	146	156
Accrual of Series B preferred stock dividends not declared		$ 4,963